Existing investor Bioventus has returned to reinvest in the bone implant provider, whose existing backers include Johnson & Johnson Innovation – JJDC.

VC firm Artis Ventures led a round for robotic surgery software developer Activ 10 months after its Sony-backed series A funding.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The medical technology provider has formed Ascendum Capital Partners in partnership with DCP Capital and Qiming Venture Partners.

The Fosun and Hidea-backed stroke therapy technology developer has raised an eight-digit sum that will help advance its product pipeline.

The oncology therapy developer has gone public in an upsized offering that provided an exit to Third Rock Ventures.

Merck & Co backed a $14m series B for SAB Biotherapeutics, which is developing drugs for two forms of coronavirus including Covid-19.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The oncology therapy developer has gone public in an upsized offering that provided exits for SoftBank Vision Fund and Alphabet's GV unit.

UPMC's patient telemedicine service Curavi Health has completed a merger that enables its founding institution to retain an equity stake.